| NCT ID | NCT07217262 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cedars-Sinai Medical Center |
| Condition | Financial Burden |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-12-22 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2025-12-22 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Proactive Costs of Care intervention is an educational intervention designed to help patients deal with the cost of cancer care. The main goal of this trial is to evaluate whether the Proactive Costs of Care intervention can be successfully delivered to cancer patients who are starting a new treatment and their caregivers by looking at how many participants complete the intervention. The other questions the trial aims to answer are whether the intervention can: * Improve confidence in solving problems related to costs of care * Reduce distress related to finances Participants will complete the Proactive Costs of Care intervention, which is an approximately 30-minute one-time session with a lay educator reviewing the Proactive Costs of Care Guide and Cost Tracker. The intervention can be completed in person, by video, and by phone. Participants will also complete two surveys- one to be completed before the intervention and one to be completed 3 months after the intervention.
Eligibility Criteria
Inclusion Criteria for Patient Participants: * Individuals 18 years old or older are included. * Individuals diagnosed with gynecologic cancer * On active systemic therapy within 30 days of enrollment * Receiving treatment at Cedars-Sinai Medical Center * Can speak, read, and understand English Inclusion Criteria for Caregiver Participants: \- Caregivers to patients who satisfy the criteria above Exclusion Criteria for Patient and Caregiver Participants: * Any patients whose records are flagged "break the glass" or "research opt out." * Cannot speak, read, or understand English * Not willing to participate in the intervention or complete surveys
Contact & Investigator
Margaret Liang, MD, MS
PRINCIPAL INVESTIGATOR
Cedars-Sinai Medical Center
Frequently Asked Questions
Who can join the NCT07217262 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Financial Burden. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07217262 currently recruiting?
Yes, NCT07217262 is actively recruiting participants. Contact the research team at Shu-Fan.Chen@cshs.org for enrollment information.
Where is the NCT07217262 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT07217262 clinical trial?
NCT07217262 is sponsored by Cedars-Sinai Medical Center. The principal investigator is Margaret Liang, MD, MS at Cedars-Sinai Medical Center. The trial plans to enroll 36 participants.